Cycloset: Medgend

Search instead for cycles

Cycloset FDA Approved Drugs

BROMOCRIPTINE MESYLATE [Bromocriptine Mesylate^{C₃₂H₄₀BrN₅O₅CH₄O₃S}]

eq 2.5mg base (oral tablet)

eq 5mg base (oral capsule)

Mylan^{Sep 24, 2004}
Paddock Llc^{Oct 1, 2008}
Sandoz Inc^{Jan 13, 1998}
Zydus Pharms Usa Inc^{Jul 30, 2008}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CYCLOSET [Bromocriptine Mesylate^{C₃₂H₄₀BrN₅O₅CH₄O₃S}]

eq 0.8mg base (oral tablet)

Veroscience^{May 5, 2009}

Administration once daily within two hours after waking in the morning for improvement of glycemic control in a type 2 diabetes patient.
Improvement of glycemic control in individuals with type 2 diabetes.
Improvements of glycemic control in individuals with type 2 diabetes who have one or more specified cardiovascular risk factors.
Treatment of type 2 diabetes by administering bromocriptine mesylate and a first-phase insulin secretagogue wherein the combined therapeutic effect is greater than the additive effect of administering each agent alone.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

PARLODEL [Bromocriptine Mesylate^{C₃₂H₄₀BrN₅O₅CH₄O₃S}]

eq 2.5mg base (oral tablet)

eq 5mg base (oral capsule)

Us Pharms Holdings I^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.